agilon health, inc. AGL

Rank #1763 · NYSE · $1.4B market cap

⚠ Going-concern flag — the auditor (Ernst & Young LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

42.7

P/E

-5.4

P/B

1.36

ROE

-25.2%

Op. Margin

-5.4%

Debt Ratio

121%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -5.4x, P/B 1.36x. Ranks in the top 56% of the universe.

Profitability ★☆☆☆☆

Weak

ROE -25.2%. Ranks in the top 79% of the universe.

Safety ★★★☆☆

Average

Debt ratio 121%. Ranks in the top 46% of the universe.

Growth ★★★★★

Excellent

Revenue growth of 80.7% year over year. Ranks in the top 5% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2021	$0.8B	$-0.1B	$-0.3B	$-0.3B	-13.4	-148
2022	$1.2B	$-0.1B	$-0.1B	$1.1B	-4.7	45
2023	$1.5B	$-0.4B	$-0.4B	$1.0B	-24.5	63
2024	$2.4B	$-0.1B	$-0.1B	$0.7B	-4.4	163
2025	$4.3B	$-0.2B	$-0.3B	$1.0B	-5.4	121

← See the full screener